Following a decree published on December 4 in the Official Journal, the vaccine against the human papillomavirus (Gardasil) is now reimbursed for boys aged 11 to 14. This is good news since the papillomavirus is responsible for sexually transmitted infections that lead to cancer in women but also in men.
Gardasil reimbursed for boys aged 11 to 14
Gardasil, a vaccine against the human papillomavirus (HPV), has already been reimbursed for girls since 2007. Since December 4, it is also reimbursed for boys aged 11 to 14 years. Recommended for girls from 11 to 14 years old and in catch-up between 15 and 19 years old, Gardasil helps protect against cervical cancer caused by certain types of HPV. On December 16, 2019, the Haute Autorité de Santé (HAS) updated its recommendations by declaring itself in favor of the expansion of vaccination against papillomavirus in boys in the French vaccination schedule: “for boys aged 11 to 14 years old. according to a 2-dose schedule, with a catch-up possible for all adolescents and young adults aged 15 to 19 years old according to a 3-dose schedule. Maintaining a specific vaccine recommendation by GARDASIL for men who have sex with men up to the age of 26, according to a 3-dose schedule ”.
A vaccine that prevents many cancers
1750. This is the number of cases of HPV-induced cancers identified in humans each year in France (anus, penis and more frequently ENT cancers), knowing that the risk of infection is higher in men having sex. sex with men. In its vaccine recommendation of December 16, 2019, the HAS recalls that the papillomavirus causes 4,580 new cases of HPV-induced cancers in women per year in France (cervix, vulva, vagina, ENT cancers). Vaccinating boys therefore not only protects girls against HPV infections but also helps reduce the transmission of papillomaviruses.
